| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |